Texas hospitals prepare to administer Covid vaccine shots in less than three weeks...
Biden transition team receives official Operation Warp Speed briefing, HHS’ Azar says, after weeks of delays...
U.S. to test run Covid vaccine distribution networks as it awaits FDA clearance in ‘just a few weeks’...
Trump's new drug-pricing plan overhauls outpatient drug pay starting Jan. 1...
Oxford-AZ Covid vaccine shows average 70% effectiveness
Pfizer and BioNTech request emergency use authorization
Pfizer: final data analysis shows vaccine is 95% effective – plans to submit to FDA in ‘days’
Oxford-AZ vaccine shows robust response among older adults
Moderna data: vaccine is more than 94% effective
Anthem: Employers increasingly looking to integrated health benefits...
Walgreens: Covid-19 Vaccines To Be Available At 9,000 Stores In 2021...
Even as COVID-19 surges, Tenet, UHS execs optimistic about Q4...
Walmart Health opens 2 more locations in Chicago...
Small doc groups struggle with telehealth, state panel finds...
Anthem sees telehealth use spike 136x for Medicare Advantage members due to COVID-19...
Moody's: Insurers will be financially 'unscathed' by COVID-19 but must adapt to industry evolution...
Trump officials see surge in signs ups for free CVS, Walgreens Covid vaccine program for seniors...
Kaiser MA plan agrees to pay $6M to DOJ to settle false claims allegations...
Hospitals across US cancel elective procedures — again...
Amazon jumps into the pharmacy business with online prescription fulfillment, free delivery for Prime members...
Walgreens, CVS Health, GoodRx, Rite Aid stocks lower after Amazon launches pharmacy business...
GoodRx co-CEO says Amazon Pharmacy is ‘complementary,’ not a competitor...
Even with pharmacy debut, Amazon unlikely to ‘blow up’ prescription pricing...
AllianceRx Walgreens Prime's new feature lets cancer patients digitally request medication refills...
UCHealth builds a successful virtual urgent care clinic with Epic and Vidyo...
Providence posts $214M loss during first nine months of 2020 due to COVID-19 impact...
CommonSpirit Health posts $167M profit in Q3 as volumes remain down due to COVID-19...
Insurers' strong financial performance continues in Q3 as they brace for a potentially rocky Q4...
You Might Like
CORONAVIRUS
Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains...
Trump coronavirus vaccine chief has had ‘no contact’ with Biden transition team...
Gene experts claim they identified human genes that can protect against Covid-19...
Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains...
Coronavirus vaccine shots could go to U.S. health workers in about a month...
FDA said to plan early December advisory meetings to discuss Covid-19 vaccines ahead of potential authorization...
Dr. Scott Gottlieb urges Covid stimulus, sacrifices: ‘This may be the last time we have to do it’...
Hospitals in half the states are facing a massive staffing shortage as Covid-19 surges...
Health systems are using AI to predict severe Covid-19 cases. But limited data could produce unreliable results...
FDA approves emergency use for first at-home Covid-19 test kit...
GOP Sen. Rob Portman: I joined J&J’s Covid vaccine trial to encourage people to get vaccinated...
Primary care docs note equipment shortages, worsening patient health amid pandemic...
Nobody has looked at AstraZeneca vaccine data yet - UK health official...
Five Health Policy Issues for CFOs to Watch Under a Biden Administration...
Premier, 34 systems partner with global medical manufacturer to create domestic gown maker...
FOLLOW HEALTHCARE REPORT ON TWITTER...
JOIN HEALTHCARE REPORT'S DAILY EMAIL LIST HERE...
OxyContin maker Purdue Pharma pleads guilty in criminal case...
A top Democrat on the House antitrust panel sets sights on Big Pharma after wrapping up tech probe...
Having shelled out $27 billion this year, Gilead's dealmakers explain their plan to make the biotech a leader in cancer drugs...
Russia plans to produce 1 billion doses of its ‘cheaper’ Covid vaccine...
Regeneron will provide 300,000 doses of Covid treatment for U.S. by early January, CEO Schleifer says...
AstraZeneca’s Covid vaccine might seem less effective than its peers — but it has some advantages...
Merck acquires OncoImmune to ramp supply of promising Covid drug...
FDA authorizes Regeneron’s Covid treatment, taken by Trump, for emergency use...
J&J readies rivals to da Vinci and Mako, eyeing new markets for robots...
Stem cell therapy for ALS fails a large clinical trial...
India’s drugmakers will be ‘essential’ in Covid-19 therapy production, says public health expert...
WuXi Biologics CEO expects approval for Covid-19 antibody treatment ‘late this year or early next year’...
House unanimously passes 2 bills requiring PBMs to release more data...
Pear rolls out digital therapeutic for insomnia...
Moderna's vaccine can last for weeks in a refrigerator, expanding an edge on rivals...
Immunity to the Coronavirus May Last Years, New Data Hint...
Singapore biotech firm hopes for ‘widespread’ release of new Covid-19 treatment by early 2021...
GenesisCare, GE ink $130M partnership to enhance cancer, cardiac care...
Breakthrough COVID vaccine tech could help defeat other diseases...
U.S. government to send out over 7 million Abbott BinaxNOW tests this week...
U.S. hospitals to restrict Lilly COVID-19 antibody treatment due to limited supply...
Buffett's Berkshire bets on Big Pharma, invests in four drugmakers...
Federal authorities issue strong warning to pharma over speaker programs and kickbacks...
Use of Rheumatoid Arthritis Drugs in Treating COVID-19 May Serve As a Game-Changer for Growth...
J&J taps into BARDA well a third time to speed up its PhIII Covid-19 vaccine trial...
Merck's Keytruda nets another approval, this time in triple negative breast cancer. Can it catch up to Tecentriq?
You Might Like
